Komori
M&A and Subsidiary Changes7177GMO Financial Holdings,Inc.Financials (excluding banks)

Notice Regarding Change in Consolidated Subsidiary (Share Transfer)

当社は、香港で店頭FX取引を行う連結子会社GMO-Z.com Forex HK Limitedの全株式を、Remi Holding Group Limitedへ譲渡する。譲渡価額は未定で、香港SFCの承認後、2026年1月以降に実行する予定。

Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
57465652
Shares
Wording
Conditional
How definitive the wording is.

This transaction

Share Transfers
CounterpartyRemi Holding Group Limited
Disclosing companyGMO Financial Holdings,Inc.
GMO-Z.com Forex HK LimitedVoting rights ownership percentageNumber of shares acquired 57,465,652 株(議決権の数:57,465,652 個)

The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.

TimelineThe spacing between the points is proportional to the actual number of days.White points represent dates designated as scheduled dates in the document.
Target company

香港における店頭 FX 取引業

Location Hong Kong(香港)Share capital 57 百万香港ドル(1,054 百万円)Date of incorporation 2011 年6月 13 日
Net Sales332 百万円(2024 年 12 月期、営業収益)
Operating profit△74 百万円(2024 年 12 月期)
Net income for the current fiscal year△74 百万円(2024 年 12 月期)
Net assets871 百万円(2024 年 12 月期)
Consideration and expenses
Acquisition price未定(譲渡時における GMO-Z.com Forex HK Limited の純資産に 100 万香港ドルを加えた額)
Type of ConsiderationCash (transfer price)
Impact on Business Performance

本件による当社の連結業績に与える影響は、軽微であると判断しております。

Procedures and assumptions
Valuation methodology譲渡時における GMO-Z.com Forex HK Limited の純資産に 100 万香港ドルを加えた額
Conditions Precedent to Execution香港の証券先物委員会(The Securities and Futures Commission、香港 SFC)による株主変更の承認
This transaction
ItemDetails
Transaction nameShare Transfers
Counterparty nameRemi Holding Group Limited
Name of the Subject CompanyGMO-Z.com Forex HK Limited
Business Description of the Subject Company香港における店頭 FX 取引業
Location of the Subject CompanyHong Kong(香港)
Capital Stock of the Subject Company57 百万香港ドル(1,054 百万円)
Date of Establishment of the Subject Company2011 年6月 13 日
Net Sales of the Subject Company332 百万円(2024 年 12 月期、営業収益)
Operating Profit of the Subject Company△74 百万円(2024 年 12 月期)
Net Income of the Subject Company△74 百万円(2024 年 12 月期)
Net Assets of the Subject Company871 百万円(2024 年 12 月期)
Acquisition price未定(譲渡時における GMO-Z.com Forex HK Limited の純資産に 100 万香港ドルを加えた額)
Type of ConsiderationCash (transfer price)
Number of shares acquired57,465,652 株(議決権の数:57,465,652 個)
Voting rights ownership percentageBefore 100% → after 0%
Impact on Business Performance本件による当社の連結業績に与える影響は、軽微であると判断しております。
Date of board resolution19 September 2025
Contract Date2025 年9月 22 日(予定)
Execution Date / Effective Date2026 年1月以降(予定)
Valuation methodology譲渡時における GMO-Z.com Forex HK Limited の純資産に 100 万香港ドルを加えた額
Conditions Precedent to Execution香港の証券先物委員会(The Securities and Futures Commission、香港 SFC)による株主変更の承認
Items this document does not state (11)
Expenses other than the acquisition priceMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Independent valuation institutionSpecial CommitteeManagement structure after acquisition

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

強みである国内事業にリソースを集中投下し、成長戦略を一層加速させるため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Change in Consolidated Subsidiary (Share Transfer) | GMO Financial Holdings,Inc. (7177) timely disclosure | Komori